Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $244.58 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tenex Health Inc. | $102.12 | 1 | $0 (2017) |
| Vericel Corporation | $53.79 | 4 | $0 (2018) |
| Bioventus LLC | $36.98 | 2 | $0 (2019) |
| Zimmer Biomet Holdings, Inc. | $25.23 | 1 | $0 (2018) |
| ERMI Inc. | $13.28 | 1 | $0 (2017) |
| Orthogenrx Inc. | $13.18 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $13.18 | 1 | Orthogenrx Inc. ($13.18) |
| 2019 | $15.39 | 1 | Bioventus LLC ($15.39) |
| 2018 | $59.73 | 3 | Zimmer Biomet Holdings, Inc. ($25.23) |
| 2017 | $156.28 | 5 | Tenex Health Inc. ($102.12) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/20/2021 | Orthogenrx Inc. | TriVisc sodium hyaluronate (Device), GenVisc 850 sodium hyaluronate | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Osteoarthritis | ||||||
| 02/07/2019 | Bioventus LLC | GELSYN 3 (Device) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Not Applicable | ||||||
| 06/12/2018 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 05/24/2018 | Zimmer Biomet Holdings, Inc. | Bellatek (Device) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Dental | ||||||
| 02/12/2018 | Vericel Corporation | MACI _ PEAK Study (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Approved Product being studied for pediatric use | ||||||
| 11/30/2017 | Tenex Health Inc. | — | Food and Beverage | In-kind items and services | $102.12 | General |
| Category: Orthopedic | ||||||
| 06/29/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $11.83 | General |
| Category: Cellular Therapy | ||||||
| 04/18/2017 | ERMI Inc. | — | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| 01/24/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $18.35 | General |
| Category: Cellular Therapy | ||||||
| 01/17/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $10.70 | General |
| Category: Cellular Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 167 | 292 | $75,321 | $14,151 |
| 2021 | 20 | 751 | 1,788 | $1.0M | $300,518 |
| 2020 | 19 | 755 | 1,369 | $417,164 | $75,364 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 110 | $33,603 | $6,384 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 41 | $18,091 | $3,539 | 19.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 25 | 47 | $18,161 | $3,200 | 17.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 42 | 81 | $2,430 | $604.30 | 24.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 11 | 13 | $3,036 | $423.70 | 14.0% |
| Q4206 | Fluid flow or fluid gf, 1 cc | Office | 2021 | 35 | 84 | $252,000 | $142,464 | 56.5% |
| Q4177 | Floweramnioflo, 0.1 cc | Office | 2021 | 25 | 560 | $403,200 | $85,298 | 21.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 148 | 324 | $98,574 | $21,624 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 138 | $60,891 | $13,465 | 22.1% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 90 | 180 | $72,643 | $13,295 | 18.3% |
| 29879 | Repair of knee joint with drilling and or scraping of the joint | Facility | 2021 | 11 | 11 | $30,276 | $5,946 | 19.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $22,033 | $3,633 | 16.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $13,981 | $2,700 | 19.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 17 | $14,003 | $2,550 | 18.2% |
| 20606 | Aspiration and/or injection of intermediate joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 22 | 26 | $9,343 | $1,719 | 18.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 93 | 185 | $5,550 | $1,473 | 26.5% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2021 | 16 | 26 | $5,756 | $955.50 | 16.6% |
| 20604 | Aspiration and/or injection of small joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 12 | 17 | $5,632 | $954.39 | 16.9% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 18 | 20 | $4,576 | $892.62 | 19.5% |
| 73560 | X-ray of knee, 1 or 2 views | Office | 2021 | 30 | 36 | $4,877 | $862.42 | 17.7% |
| 73502 | X-ray of hip with pelvis, 2-3 views | Office | 2021 | 22 | 27 | $4,942 | $843.36 | 17.1% |
| 73100 | X-ray of wrist, 2 views | Office | 2021 | 15 | 26 | $3,580 | $688.50 | 19.2% |
| 20551 | Injections of tendon attachment to bone | Office | 2021 | 12 | 15 | $3,461 | $605.91 | 17.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 15 | 18 | $2,413 | $362.92 | 15.0% |
| 73620 | X-ray of foot, 2 views | Office | 2021 | 12 | 13 | $1,461 | $184.64 | 12.6% |
About Dr. Duncan Wells, M.D
Dr. Duncan Wells, M.D is a Orthopaedic Surgery healthcare provider based in Woodstock, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407881253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duncan Wells, M.D has received a total of $244.58 in payments from pharmaceutical and medical device companies, with $13.18 received in 2021. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($244.58).
As a Medicare-enrolled provider, Wells has provided services to 1,673 Medicare beneficiaries, totaling 3,449 services with total Medicare billing of $390,033. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Woodstock, GA
- Active Since 07/11/2006
- Last Updated 08/19/2015
- Taxonomy Code 207X00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407881253
Products in Payments
- MACI (Drug) $40.88
- Bellatek (Device) $25.23
- Durolane (Device) $21.59
- GELSYN 3 (Device) $15.39
- TriVisc sodium hyaluronate (Device) $13.18
- MACI _ PEAK Study (Drug) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Woodstock
Dr. Joel Pranckun, D.o, D.O
Orthopaedic Surgery — Payments: $25,191
Mesfin Shibeshi, Do, DO
Orthopaedic Surgery — Payments: $11,941
Dr. Dana Tarandy, Md, MD
Orthopaedic Surgery — Payments: $3,008
Karthikeyan Ponnusamy, M.d, M.D
Orthopaedic Surgery — Payments: $582.10
Dr. William Lennen, Md, MD
Orthopaedic Surgery — Payments: $41.84